AVAILABLE MEDICINE FOR Dolutegravir,emtricitabine,tenofovir Alafenamide
There are no products to list.
Introduction to Dolutegravir,emtricitabine,tenofovir Alafenamide
Dolutegravir, Emtricitabine, and Tenofovir Alafenamide is a combination regimen consisting of antiviral medications, which was approved for its medical use in December 2020. This is a combination of antiretroviral therapy used for the treatment of HIV-1.
How it Works:
- Dolutegravir: Blocks HIV integrase, preventing the integration of viral DNA into human DNA.
- Emtricitabine and Tenofovir Alafenamide: Inhibit reverse transcriptase, stopping HIV from replicating.
Uses:
Treatment of HIV-1 infection in adults and adolescents.
Side Effects:
- Headache
- nausea
- fatigue
- Rare: kidney problems
- liver issues.
